Capacity in Biopharmaceutical Manufacturing

In today's featured interview Peter Moesta, Ph.D., Bristol-Myers Squibb sits down at the 2013 BioProcess International Event to discuss the current pipeline at BMS, cell culture purification and takes an in-depth look at manufacturing capabilities of the companies - including flexible manufacturing, emerging markets and how they would produce medication in those countries.

Watch the full interview here:


This year at BioProcess International, we will continue our focus of the emerging trends and technologies to improve the quality and speed of bioprocess manufacturing.  This year, Philippe-Alexandre Gilbert, Ph.D., Head of Upstream Development of Novartis Vaccines & Diagnostics will be joining us to present Biomanufacturing Strategies to Prepare for the Pipeline of the Future.  For more information on this session and the rest of the program, download the brochure.  If you'd like to join us in Boston this October 20-23, as a reader of this blog when you register to join us and mention code BPI14BLOG, you can save 20% off the standard rate!  Do you have any questions or want to get involved with BPI 2014?  Email Jennifer Pereira.

Share this article with your social network, just click below to share now!

Share |